Department of Biotechnology, College of Life Sciences and Biotechnology, Korea University, Seoul, 02841, Republic of Korea.
Exp Mol Med. 2023 Sep;55(9):1858-1871. doi: 10.1038/s12276-023-01053-6. Epub 2023 Sep 11.
The cluster of differentiation 1 (CD1) molecule differs from major histocompatibility complex class I and II because it presents glycolipid/lipid antigens. Moreover, the CD1-restricted T cells that recognize these self and foreign antigens participate in both innate and adaptive immune responses. CD1s are constitutively expressed by professional and nonprofessional antigen-presenting cells in mucosal tissues, namely, the skin, lung, and intestine. This suggests that CD1-reactive T cells are involved in the immune responses of these tissues. Indeed, evidence suggests that these cells play important roles in diverse diseases, such as inflammation, autoimmune disease, and infection. Recent studies elucidating the molecular mechanisms by which CD1 presents lipid antigens suggest that defects in these mechanisms could contribute to the activities of CD1-reactive T cells. Thus, improving our understanding of these mechanisms could lead to new and effective therapeutic approaches to CD1-associated diseases. In this review, we discuss the CD1-mediated antigen presentation system and its roles in mucosal tissue immunity.
分化簇 1(CD1)分子与主要组织相容性复合体 I 类和 II 类不同,因为它呈递糖脂/脂质抗原。此外,识别这些自身和外来抗原的 CD1 限制性 T 细胞参与固有和适应性免疫反应。CD1 在黏膜组织(即皮肤、肺和肠)中的专业和非专业抗原呈递细胞中持续表达。这表明 CD1 反应性 T 细胞参与这些组织的免疫反应。事实上,有证据表明这些细胞在多种疾病中发挥重要作用,如炎症、自身免疫性疾病和感染。最近阐明 CD1 呈递脂质抗原的分子机制的研究表明,这些机制的缺陷可能导致 CD1 反应性 T 细胞的活性。因此,提高我们对这些机制的理解可能会导致针对 CD1 相关疾病的新的有效治疗方法。在这篇综述中,我们讨论了 CD1 介导的抗原呈递系统及其在黏膜组织免疫中的作用。